Xinping Pan

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

China National Biotechnology (China)(Current)

China National Pharmaceutical Group Corporation (China)

Viva Biotech (China)

Xinping Pan is an author at China National Biotechnology (China) specializing in combination immunotherapy, cancer immunotherapy, and tumor immunology.

Publications per year

2022–2025

Publications

VG161 activates systemic antitumor immunity in pancreatic cancer models as a novel oncolytic herpesvirus expressing multiple immunomodulatory transgenes

Yinan Shen, Wei Song, Danni Lin et al. · Journal of Medical Virology · 2022 · 33 citations · Full text

Medicine, Immunology, Oncology +17

Lipid Nanoparticles Consisting of Sterol-Conjugated Ionizable Lipids Enable Prolonged and Safe mRNA Delivery

Yiming Zhou, Yanxia Gao, Xinping Pan et al. · ACS Applied Materials & Interfaces · 2025 · 11 citations

Pharmacy, Pharmaceutical Biotechnology, Pharmaceutics +17

Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine

Changrui Lu, Yuntao Zhang, Xiaohu Liu et al. · Antiviral Research · 2023 · 10 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

1–3 of 3